We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEfficacy and safety of ezetimibe 40 mg vs. ezetimibe 10 mg in the treatment of patients with homozygous sitosterolaemia.AuthorsMusliner, T; Cselovszky, D; Sirah, W; McCrary Sisk, C; Sapre, A; Salen, G; Lütjohann, D; von Bergmann, KAbstractTo assess the effect of ezetimibe (EZE) 40 mg/day on non-cholesterol sterol plasma concentrations in patients with homozygous sitosterolaemia (HoS).PublicationInternational journal of clinical practice, 2008, Vol 62, Issue 7, p995ISSN1742-1241Publication typeJournal ArticleDOI10.1111/j.1742-1241.2008.01786.x